These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 28303435)

  • 1. Systemic Combination Chemotherapy in Elderly Pancreatic Cancer: a Review.
    Garcia G; Odaimi M
    J Gastrointest Cancer; 2017 Jun; 48(2):121-128. PubMed ID: 28303435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adjuvant Chemotherapy after Surgery for Pancreatic Cancer].
    Furuse J
    Gan To Kagaku Ryoho; 2016 Feb; 43(2):160-4. PubMed ID: 27067680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancements in the management of pancreatic cancer: 2013.
    Saif MW
    JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Toxicity of Different Chemotherapy Regimens in the Treatment of Advanced or Metastatic Pancreatic Cancer: A Network Meta-Analysis.
    Liu GF; Li GJ; Zhao H
    J Cell Biochem; 2018 Jan; 119(1):511-523. PubMed ID: 28608558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for pancreatic cancer.
    Springfeld C; Jäger D; Büchler MW; Strobel O; Hackert T; Palmer DH; Neoptolemos JP
    Presse Med; 2019 Mar; 48(3 Pt 2):e159-e174. PubMed ID: 30879894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
    Sohal DP; Mangu PB; Khorana AA; Shah MA; Philip PA; O'Reilly EM; Uronis HE; Ramanathan RK; Crane CH; Engebretson A; Ruggiero JT; Copur MS; Lau M; Urba S; Laheru D
    J Clin Oncol; 2016 Aug; 34(23):2784-96. PubMed ID: 27247222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Best practices for the treatment of metastatic pancreatic adenocarcinoma: the therapeutic landscape in 2017.
    Cinar P; Ko AH
    Chin Clin Oncol; 2017 Jun; 6(3):29. PubMed ID: 28705006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Standards of Chemotherapy for Pancreatic Cancer.
    Saung MT; Zheng L
    Clin Ther; 2017 Nov; 39(11):2125-2134. PubMed ID: 28939405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of elderly patients with unresectable pancreatic cancer.
    Kobayashi S; Ueno M; Ishii H; Furuse J
    Jpn J Clin Oncol; 2022 Sep; 52(9):959-965. PubMed ID: 35789391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second line treatment options for pancreatic cancer.
    Passero FC; Saif MW
    Expert Opin Pharmacother; 2017 Oct; 18(15):1607-1617. PubMed ID: 28820270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Approaches for Metastatic Pancreatic Adenocarcinoma.
    Rubinson DA; Wolpin BM
    Hematol Oncol Clin North Am; 2015 Aug; 29(4):761-76. PubMed ID: 26226909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cetuximab: still an option in the treatment of pancreatic cancer?
    Faloppi L; Andrikou K; Cascinu S
    Expert Opin Biol Ther; 2013 May; 13(5):791-801. PubMed ID: 23560505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of FOLFIRINOX in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: A retrospective analysis.
    Baldini C; Escande A; Bouché O; El Hajbi F; Volet J; Bourgeois V; Renaut Vantroys T; Ploquin A; Desauw C; Hebbar M
    Pancreatology; 2017; 17(1):146-149. PubMed ID: 28040425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer.
    Caparello C; Meijer LL; Garajova I; Falcone A; Le Large TY; Funel N; Kazemier G; Peters GJ; Vasile E; Giovannetti E
    World J Gastroenterol; 2016 Aug; 22(31):6987-7005. PubMed ID: 27610011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis.
    Gresham GK; Wells GA; Gill S; Cameron C; Jonker DJ
    BMC Cancer; 2014 Jun; 14():471. PubMed ID: 24972449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MM-398 (nanoliposomal irinotecan): emergence of a novel therapy for the treatment of advanced pancreatic cancer.
    Carnevale J; Ko AH
    Future Oncol; 2016 Feb; 12(4):453-64. PubMed ID: 26685802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic pancreatic ductal adenocarcinoma: diagnosis and treatment with a view to the future.
    Pokorny AMJ; Chin VT; Nagrial AM; Yip D; Chantrill LA
    Intern Med J; 2018 Jun; 48(6):637-644. PubMed ID: 29898269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Currently available first-line drug therapies for treating pancreatic cancer.
    Olson JL; Bold RJ
    Expert Opin Pharmacother; 2018 Dec; 19(17):1927-1940. PubMed ID: 30325679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to treat pancreatic adenocarcinoma in elderly: How far can we go in 2017?
    Gilabert M; Raoul JL; Rousseau F
    J Geriatr Oncol; 2017 Nov; 8(6):407-412. PubMed ID: 28888554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoliposomal irinotecan plus fluorouracil and folinic acid: a new treatment option in metastatic pancreatic cancer.
    Ur Rehman SS; Lim K; Wang-Gillam A
    Expert Rev Anticancer Ther; 2016 May; 16(5):485-92. PubMed ID: 27043737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.